Literature DB >> 30908702

Evidence of differential microbiomes in healing versus non-healing diabetic foot ulcers prior to and following foot salvage therapy.

Ashlee MacDonald1, James D Brodell1, John L Daiss2, Edward M Schwarz2, Irvin Oh1.   

Abstract

Diabetic foot ulcers (DFU) contribute to 80% of lower extremity amputations. Although physicians currently rely on clinical signs along with non-specific biomarkers of infection, such as erythrocyte sedimentation rate and C-reactive protein, to diagnose and monitor DFU, there is no specific and sensitive measure available to monitor or prognosticate the success of foot salvage therapy (FST). To address this we performed a prospective, observational microbiome analysis to test the hypotheses that: (i) the initial microbiomes of healed versus non-healed DFU are distinct; (ii) the microbial load, diversity and presence of pathogenic organism of the DFU change in response to antibiotics treatment; and (iii) the changes in the DFU microbiome during treatment are prognostic of clinical outcome. To test this, microbiome analyses were performed on 23 DFU patients undergoing FST, in which wound samples were collected at zero, four, and eight weeks following wound debridement and antibiotics treatment. Bacterial abundance was determined using quantitative polymerase chain reaction (qPCR). Eleven patients healed their DFU, while FDT failed to heal DFU in the other 12 patients. Microbiome results demonstrated that healing DFUs had a larger abundance Actinomycetales and Staphylococcaceae (p < 0.05), while DFUs that did not heal had a higher abundance of Bacteroidales and Streptococcaceae (p < 0.05). FST marked increases Actinomycetales in DFU, and this increase is significantly greater in patients that healed (p < 0.05). Future studies to confirm the differential microbiomes, and that increasing Actinomycetales is prognostic of successful FST are warranted. Statement of Clinical Significance: Tracking changes in the prevalence of pathogens in diabetic foot ulcers may be a clinical tool for monitoring treatment response to foot salvage therapy and prognosticating the need for further surgical intervention. The initial wound sample microbiome may provide important prognostic information on the eventual clinical outcome of foot salvage therapy. It may serve as an important clinical tool for patient counseling and making surgical decision of pursuing foot salvage versus amputation.
© 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1596-1603, 2019. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  diabetic foot ulcer; foot salvage therapy; microbiome; osteomyelitis; prognosis

Mesh:

Substances:

Year:  2019        PMID: 30908702      PMCID: PMC6659747          DOI: 10.1002/jor.24279

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  24 in total

1.  Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response.

Authors:  Elizabeth A Grice; Evan S Snitkin; Laura J Yockey; Dustin M Bermudez; Kenneth W Liechty; Julia A Segre
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-28       Impact factor: 11.205

2.  Role of bone biopsy specimen culture in the management of diabetic foot osteomyelitis.

Authors:  T P Elamurugan; S Jagdish; Vikram Kate; Subhash Chandra Parija
Journal:  Int J Surg       Date:  2010-12-01       Impact factor: 6.071

3.  Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs.

Authors:  Caitlin W Hicks; Shalini Selvarajah; Nestoras Mathioudakis; Ronald E Sherman; Kathryn F Hines; James H Black; Christopher J Abularrage
Journal:  Ann Vasc Surg       Date:  2016-02-22       Impact factor: 1.466

4.  Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2).

Authors:  S D Bentley; K F Chater; A-M Cerdeño-Tárraga; G L Challis; N R Thomson; K D James; D E Harris; M A Quail; H Kieser; D Harper; A Bateman; S Brown; G Chandra; C W Chen; M Collins; A Cronin; A Fraser; A Goble; J Hidalgo; T Hornsby; S Howarth; C-H Huang; T Kieser; L Larke; L Murphy; K Oliver; S O'Neil; E Rabbinowitsch; M-A Rajandream; K Rutherford; S Rutter; K Seeger; D Saunders; S Sharp; R Squares; S Squares; K Taylor; T Warren; A Wietzorrek; J Woodward; B G Barrell; J Parkhill; D A Hopwood
Journal:  Nature       Date:  2002-05-09       Impact factor: 49.962

5.  2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; Paul B Cornia; James C Pile; Edgar J G Peters; David G Armstrong; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Michael S Pinzur; Eric Senneville
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

Review 6.  Osteomyelitis of the foot in diabetic patients.

Authors:  B A Lipsky
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

7.  The effect of antibiotics on the microbiome in acute exacerbations of chronic rhinosinusitis.

Authors:  Mark A Merkley; Tristan C Bice; Alex Grier; Alexis M Strohl; Li-Xing Man; Steven R Gill
Journal:  Int Forum Allergy Rhinol       Date:  2015-07-30       Impact factor: 3.858

Review 8.  Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration?

Authors:  Jeffrey M Robbins; Gerald Strauss; David Aron; Jodi Long; Jennifer Kuba; Yelena Kaplan
Journal:  J Am Podiatr Med Assoc       Date:  2008 Nov-Dec

9.  Diabetic foot ulcer microbiome: one small step for molecular microbiology . . . One giant leap for understanding diabetic foot ulcers?

Authors:  Benjamin A Lipsky; Jean-Louis Richard; Jean-Philippe Lavigne
Journal:  Diabetes       Date:  2013-03       Impact factor: 9.461

10.  The neuropathic diabetic foot ulcer microbiome is associated with clinical factors.

Authors:  Sue E Gardner; Stephen L Hillis; Kris Heilmann; Julia A Segre; Elizabeth A Grice
Journal:  Diabetes       Date:  2012-11-08       Impact factor: 9.461

View more
  8 in total

Review 1.  Staphylococcus aureus Osteomyelitis: Bone, Bugs, and Surgery.

Authors:  Kenneth L Urish; James E Cassat
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

2.  Comparative study of culture, next-generation sequencing, and immunoassay for identification of pathogen in diabetic foot ulcer.

Authors:  Jason Scott Lipof; Courtney Marie Cora Jones; John Daiss; Irvin Oh
Journal:  J Orthop Res       Date:  2021-02-15       Impact factor: 3.494

3.  Emerging Diabetic Foot Ulcer Microbiome Analysis Using Cutting Edge Technologies.

Authors:  Brian M Schmidt
Journal:  J Diabetes Sci Technol       Date:  2021-02-12

Review 4.  Evolving concepts in bone infection: redefining "biofilm", "acute vs. chronic osteomyelitis", "the immune proteome" and "local antibiotic therapy".

Authors:  Elysia A Masters; Ryan P Trombetta; Karen L de Mesy Bentley; Brendan F Boyce; Ann Lindley Gill; Steven R Gill; Kohei Nishitani; Masahiro Ishikawa; Yugo Morita; Hiromu Ito; Sheila N Bello-Irizarry; Mark Ninomiya; James D Brodell; Charles C Lee; Stephanie P Hao; Irvin Oh; Chao Xie; Hani A Awad; John L Daiss; John R Owen; Stephen L Kates; Edward M Schwarz; Gowrishankar Muthukrishnan
Journal:  Bone Res       Date:  2019-07-15       Impact factor: 13.567

Review 5.  The dynamic wound microbiome.

Authors:  Chunan Liu; Alise J Ponsero; David G Armstrong; Benjamin A Lipsky; Bonnie L Hurwitz
Journal:  BMC Med       Date:  2020-11-24       Impact factor: 8.775

6.  Next-Generation Sequencing for Pathogen Identification in Infected Foot Ulcers.

Authors:  Yoonjung Choi; Eimi Oda; Olivia Waldman; Thomas Sajda; Christopher Beck; Irvin Oh
Journal:  Foot Ankle Orthop       Date:  2021-07-12

7.  Priority effects dictate community structure and alter virulence of fungal-bacterial biofilms.

Authors:  J Z Alex Cheong; Chad J Johnson; Hanxiao Wan; Aiping Liu; John F Kernien; Angela L F Gibson; Jeniel E Nett; Lindsay R Kalan
Journal:  ISME J       Date:  2021-02-08       Impact factor: 10.302

Review 8.  Bioactive Antimicrobial Peptides as Therapeutic Agents for Infected Diabetic Foot Ulcers.

Authors:  Jessica Da Silva; Ermelindo C Leal; Eugénia Carvalho
Journal:  Biomolecules       Date:  2021-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.